gvtcx

Next Generation Sequencing Testing (NGS)

NHS Blood and Transplant Published 25 Jun 2026 Find a Tender

key details

Value£600,000 (£660,000 inc. VAT)
Statuscomplete
Category (CPV) 72225000
RegionSouth West
Deadline20 Feb 2026
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-0514f8

Award

SupplierValueDateStatus
SGS United Kingdom Limited £407,200 23 Jun 2026 pending

description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
15 May 2025 Preliminary market engagement (UK2) Procurement Act 2023 021932-2025
12 Jan 2026 Tender notice (UK4) Procurement Act 2023 002096-2026
26 Jan 2026 Tender notice (UK4) Procurement Act 2023 006523-2026
25 Jun 2026 Contract award (UK6) Procurement Act 2023 059773-2026

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.